Interview with Gabriella’s Kitchen CEO Margot Micallef
Ryan Allway
March 20th, 2019
Exclusive, News, Top News
CFN Media recently sat down with Gabriella’s Kitchen (CSE: GABY) (OTCBB:GABLF) CEO Margot Micallef to discuss the global implications of Gaby’s innovative products.
New beginnings
Gabriella’s Kitchen is a cannabis wellness company founded in health and nutrition. Spurred by a dire cancer prognosis, sisters Gabriella and Margot sought a healthier lifestyle that might prolong Gabriella’s life.
Thus, Gabriella’s Kitchen was formed. Proving that consumer demand was real, the business took off. Gaby went from 200 retail outlets to 3,400, and growing to 2018 revenue of over $9 million dollars.
Leading the Field
As CEO, Micallef’s visionary role was driven by her sister’s condition as she searched wellness and nutrition science relentlessly. Though she had never previously explored cannabis products, her quest led her to the many case studies and current research based on the health attributes associated with the cannabis plant.
Convinced that the properties of cannabis could enhance her products, Micallef sought out the pioneers in the field and found Mara Gordon, process engineer and CEO of The Oil Plant (TOP), and Jamie Fay, a seasoned executive in packaged goods.
Gordon had her own health problems and her search for wellness paralleled Micallef’s. The two joined forces, merged companies, and have now released many new products, infused with cannabis and healthy ingredients, to promote the field of well being through nutrition.
The documentary “Weed the People” features Gordon’s groundbreaking and data-oriented work. Working with clinicians and physicians, Gordon explores five families that have successfully used cannabis to treat a variety of cancers. Gordon’s previous advisory status at GABY was so successful that she was assigned Chief Research Officer. With Gordon’s proprietary knowledge and TOP’s cost effective, high grade, whole plant oil extraction, all the right ingredients came together for GABY’s kitchen.
Meanwhile, Fay has senior-level executive experience from Hain Celestial, Nature’s Path Foods and Mars Inc. and brings extensive packaged goods expertise to the table. He joins his former colleagues, Maureen Putman and Irwin Simon, in applying natural and organic food industry successes to the nascent cannabis industry.
Looking Ahead
Gifted with gratitude and acknowledgement of Gordon’s work, Micallef seeks to make cannabis available to all who are suffering with illness through legalization. Micallef recognizes California, currently the greatest producer of cannabis and also the largest market of wellness products, to be a forerunner in consumer habits. Micallef is banking on the “halo” effect as legalization spreads and markets go global.
The TOP acquisition provided the company with a Type-6 non-volatile manufacturing license to operate a cannabis extraction and infusion facility in the state of California. GABY is also in the process of acquiring Sonoma Pacific Distribution, a leading California cannabis distribution and marketing company. The addition of Sonoma’s licensed distribution channel gives the company control of the product life cycle from conception through manufacturing to wholesale in the world’s largest legal cannabis market. GABY is also aiming for markets in Canada, where federal legalization has recently occurred and where edibles are expected to be legalized later this year.
The company also recently joint ventured with Eximius Coffee to introduce cannabis and CBD-infused ready-to-drink cold brew coffee and pods. The coffees for the licensed dispensary channel will be manufactured at TOP while those aimed for the mainstream grocery and convenience channel using hemp CBD oil will be manufactured through a partnership relationship with an Oregon facility. In addition to near-term revenue potential, the deal could pave the way to wider entry into the beverage market.
GABY’s ability to adapt and expand is well ensured, as exports out of Canada are free to fly to global markets far and wide. With this distribution infrastructure in place, Gabriella’s Kitchen continues to be a thought leader and intends to leave a global footprint for their innovative products. As such, the company offers the opportunity for investors to participate in an early stage cannabis play that looks well-positioned to take off.
For more information, Gabriella’s Kitchen can be found at: www.gabriellas-kitchen.com
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
